Sector News

Clariant to divest healthcare packaging business segment

July 23, 2019
Chemical Value Chain

Clariant has signed an agreement with respect to the sale of its Healthcare Packaging business to a newly-formed affiliate of Arsenal Capital Partners. The total consideration of the sale amounts to approximately CHF 308 million payable at closing, which is expected in Q4 2019. The total consideration is equivalent to 13.2 times adjusted FY2018 EBITDA. The closing of the transaction is subject to customary conditions and approvals.

Clariant’s Healthcare Packaging business offers products used to protect pharmaceutical products from moisture and oxygen. This includes customizable, high-quality drop-in products (canisters and packets), Integrated Desiccant Systems and specially designed plastic bottles containing oxygen barrier materials. In 2018, the Healthcare Packaging business generated sales of around CHF 135 million. The business has manufacturing facilities in the USA, France, China and India and employs around 600 employees.

By Mary Page Bailey

Source: Chemical Engineering

Related News

May 1, 2021

BASF with strong start to 2021 business year

Chemical Value Chain

BASF increased sales by €2.6 billion compared with the first quarter of 2020 to €19.4 billion. This was mainly due to higher prices and volume growth.

May 1, 2021

Air Products acquires full ownership of China gasification joint venture

Chemical Value Chain

Air Products acquired General Electric’s gasification business in 2018 which included the 50% stake in a syngas joint venture with China Shenhua Coal to Liquid and Chemical, a subsidiary of China Energy Group.

May 1, 2021

EVP Yara Europe Tove Andersen appointed President & CEO in Tomra Systems ASA

Chemical Value Chain

Tove Andersen, currently EVP Yara Europe, has been appointed President and CEO of Tomra Systems ASA. She will take up the new position latest 1 November 2021.

Send this to a friend